Zevra therapeutics' president and chief executive officer issues letter to stockholders highlighting recent key accomplishments and outlook for 2024

Celebration, fla., april 29, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a rare disease therapeutics company, today announced that neil f. mcfarlane, zevra's president and chief executive officer, has issued a letter to stockholders providing a review of key accomplishments and outlook for 2024.
ZVRA Ratings Summary
ZVRA Quant Ranking